What's in Applied Therapeutics, Inc.'s pipeline?

Applied Therapeutics, Inc. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Applied Therapeutics, Inc.'s portfolio?

Top competitors by shared drug class: Sumitomo Pharma Co., Ltd., Takeda.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/applied-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Applied Therapeutics, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Applied Therapeutics, Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
AT-007	AT-007	phase 3	Aldose reductase inhibitor	Aldose reductase	Endocrinology / Diabetes

Therapeutic area mix

Endocrinology / Diabetes · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Sumitomo Pharma Co., Ltd. · 1 shared drug class
Takeda · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Applied Therapeutics, Inc.:

Cite this brief

Drug Landscape (2026). Applied Therapeutics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/applied-therapeutics-inc. Accessed 2026-06-10.